Pembrolizumab treatment of advanced cervical cancer: updated results from the phase II KEYNOTE-158 study
Hyun Cheol Chung, Jean‐Pierre Delord, Ruth Perets, Antoîne Italiano, Ronnie Shapira‐Frommer, Lyudmila Manzuk, Sarina A. Piha‐Paul, Lei Xu, Fan Jin, Kevin Norwood, Alexandra Léary
Topics & Concepts
MedicinePembrolizumabCervical cancerCohortCancerInternal medicineClinical endpointOncologyInterim analysisProgression-free survivalChemotherapySurgeryClinical trialImmunotherapyEndometrial and Cervical Cancer TreatmentsCancer Immunotherapy and BiomarkersColorectal and Anal Carcinomas